TMX Group (OTCMKTS:TMXXF – Get Free Report) is expected to be issuing its results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $333.17 million for the quarter.
TMX Group Stock Performance
TMXXF stock opened at $41.08 on Tuesday. The company’s fifty day simple moving average is $38.32 and its 200 day simple moving average is $36.78. TMX Group has a 12-month low of $31.66 and a 12-month high of $41.94.
Analyst Ratings Changes
Several research analysts have recently weighed in on TMXXF shares. Scotiabank reissued an “outperform” rating on shares of TMX Group in a research report on Monday, August 3rd. Canadian Imperial Bank of Commerce initiated coverage on TMX Group in a research note on Monday, August 17th. They issued an “outperform” rating on the stock. Finally, National Bank Financial upgraded TMX Group from a “sector perform” rating to an “outperform” rating in a research report on Monday, July 27th. One investment analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company’s stock. According to data from MarketBeat, TMX Group currently has an average rating of “Buy”.
Read Our Latest Analysis on TMXXF
TMX Group Company Profile
TMX Group Limited is a Canadian financial markets infrastructure company that operates marketplaces, clearinghouses, depositories and market-data businesses. Its principal markets include Toronto Stock Exchange (TSX), TSX Venture Exchange, TSX Alpha Exchange and Montréal Exchange. These platforms support the listing and trading of equities, fixed-income products, derivatives and other financial instruments.
Through its clearing and settlement businesses, including Canadian Derivatives Clearing Corporation and CDS Clearing and Depository Services, TMX Group provides clearing, settlement, custody and depository services for Canadian capital markets.
Further Reading
- Five stocks we like better than TMX Group
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for TMX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TMX Group and related companies with MarketBeat.com's FREE daily email newsletter.
